Neuronetics insider buys 150K STIM shares

Neuronetics, Inc. 10% owner Jorey Chernett reported open-market purchases of a total of 150,000 shares of common stock.

Accepted by SEC EDGAR 03/27/2026 - 09:33 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Neuronetics, Inc. 10% owner Jorey Chernett reported open-market purchases of a total of 150,000 shares of common stock. The buys occurred on March 25 and March 26 at reported prices of $1.40 and $1.44 per share, respectively. After these transactions, Chernett directly owns 8,893,276 Neuronetics shares. A footnote explains that one purchase reflects a weighted-average price for multiple trades executed between $1.38 and $1.42 per share.

Insider Trade Summary

Net Buyer: 150,000 shares

Net Buy 2 txns

Insider Chernett Jorey

Role 10% Owner

Bought 150,000 shs ($211K)

Increase in Position 1.7%

Type	Security	Shares	Price	Value
Purchase	Common Stock	25,000	$1.44	$36K
Purchase	Common Stock	125,000	$1.40	$175K

Holdings After Transaction: Common Stock — 8,893,276 shares (Direct)

Holdings Before and After: Common Stock, 8,743,276 to 8,893,276 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Jorey Chernett report for Neuronetics (STIM)?

Jorey Chernett reported buying 150,000 Neuronetics common shares in the open market. The purchases took place over two days and reflect a net increase in his direct ownership position in the company’s stock.

On what dates did Jorey Chernett buy Neuronetics (STIM) shares?

Chernett bought Neuronetics shares on March 25 and March 26. These consecutive-day open-market purchases together totaled 150,000 shares of common stock, according to the Form 4 insider transaction disclosure.

What prices did Jorey Chernett pay for Neuronetics (STIM) stock?

The reported transaction prices were $1.40 and $1.44 per share. A footnote adds that one day’s purchase reflects a weighted-average price for trades executed between $1.38 and $1.42 per share, rounded to the nearest cent.

How many Neuronetics (STIM) shares does Jorey Chernett own after these trades?

After the reported purchases, Chernett directly holds 8,893,276 Neuronetics common shares. This figure reflects his position following the two open-market buy transactions disclosed in the Form 4 filing.

Is Jorey Chernett a significant shareholder of Neuronetics (STIM)?

Yes. The Form 4 identifies Chernett as a ten percent owner of Neuronetics. His direct holdings of 8,893,276 common shares following the reported trades underscore his status as a large shareholder in the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		P		125,000	A	$1.4(1)	8,868,276	D
Common Stock	03/26/2026		P		25,000	A	$1.44	8,893,276	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)